What is Protagonist Therapeutics's net investment in lease?

Protagonist Therapeutics (PTGX) reported net investment in lease of $7.39M in Q1 2026.

How has Protagonist Therapeutics's net investment in lease changed year-over-year?

Protagonist Therapeutics's net investment in lease decreased by 17.9% year-over-year, from $9M to $7.39M.

What is the long-term trend for Protagonist Therapeutics's net investment in lease?

Over 5 years (2020 to 2025), Protagonist Therapeutics's net investment in lease has grown at a 9.6% compound annual growth rate (CAGR), from $4.95M to $7.83M.

Protagonist Therapeutics PTGX Net Investment in Lease

Net Investment in Lease at other companies

Apogee Therapeutics, Inc.APGE

——

Kymera TherapeuticsKYMR

——

ImmunityBio, Inc.IBRX

——

Arrowhead ResearchARWR

——

Summit TherapeuticsSMMT

——

PTC TherapeuticsPTCT

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's net investment in lease?: Protagonist Therapeutics (PTGX) reported net investment in lease of $7.39M in Q1 2026.
How has Protagonist Therapeutics's net investment in lease changed year-over-year?: Protagonist Therapeutics's net investment in lease decreased by 17.9% year-over-year, from $9M to $7.39M.
What is the long-term trend for Protagonist Therapeutics's net investment in lease?: Over 5 years (2020 to 2025), Protagonist Therapeutics's net investment in lease has grown at a 9.6% compound annual growth rate (CAGR), from $4.95M to $7.83M.